Blockbuster drug Humira finally faces low-cost rivals

Blockbuster drug Humira finally faces low-cost rivals

AbbVie’s Humira was the world’s best-selling drug for many years. It now faces competition for knockoffs that cost a fraction of its price. David J. Philip/AP hide caption toggle caption on/off David J. Philip/AP AbbVie’s Humira was the world’s best-selling drug for many years. It now faces competition for knockoffs that cost a fraction of …

Blockbuster drug Humira finally faces low-cost rivals Read More »